Analystreport

Coherus BioSciences, Inc. (NASDAQ: CHRS) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com